DaTscan SPECT tracer changes Parkinson's treatment

April 26, 2012

Results from a randomized clinical trial being presented at this week's American Academy of Neurology (AAN) meeting suggest that the SPECT radiopharmaceutical DaTscan (ioflupane I-123 injection) can help clinicians distinguish between tremors due to Parkinson's disease and non-Parkinsonian essential tremor, expediting appropriate treatment.